Cargando…
A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful
A 49-year-old Japanese male was managed by mechanical ventilation due to coronavirus disease 2019 (COVID-19) pneumonia. Favipiravir as an antiviral therapy, and anti-inflammatory treatment were administered. SARS-CoV-2 RNA was detected in serum by the loop-mediated isothermal amplification (LAMP) me...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547611/ https://www.ncbi.nlm.nih.gov/pubmed/33268271 http://dx.doi.org/10.1016/j.jiac.2020.10.011 |
_version_ | 1783592457536012288 |
---|---|
author | Hirouchi, Takatomo Ota, Shinichiro Mashima, Dai Boku, Ryuichi Yoshida, Yuto Iwata, Koki Shinada, Kanako Matsumoto, Takashi Morikawa, Miwa Sato, Takashi Shinoda, Masahiro Kamachi, Kenichi Shinkai, Masaharu |
author_facet | Hirouchi, Takatomo Ota, Shinichiro Mashima, Dai Boku, Ryuichi Yoshida, Yuto Iwata, Koki Shinada, Kanako Matsumoto, Takashi Morikawa, Miwa Sato, Takashi Shinoda, Masahiro Kamachi, Kenichi Shinkai, Masaharu |
author_sort | Hirouchi, Takatomo |
collection | PubMed |
description | A 49-year-old Japanese male was managed by mechanical ventilation due to coronavirus disease 2019 (COVID-19) pneumonia. Favipiravir as an antiviral therapy, and anti-inflammatory treatment were administered. SARS-CoV-2 RNA was detected in serum by the loop-mediated isothermal amplification (LAMP) method on Day 9; favipiravir treatment was continued. On Day 13, negative serum RNA was confirmed, followed by mechanical ventilation was removed. On Day 23, LAMP negative was confirmed in nasopharynx, after that the patient discharged on Day 27. We could treat successfully for severe COVID-19 pneumonia based on the LAMP method. We consider this method will be useful in COVID-19 treatment. |
format | Online Article Text |
id | pubmed-7547611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75476112020-10-13 A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful Hirouchi, Takatomo Ota, Shinichiro Mashima, Dai Boku, Ryuichi Yoshida, Yuto Iwata, Koki Shinada, Kanako Matsumoto, Takashi Morikawa, Miwa Sato, Takashi Shinoda, Masahiro Kamachi, Kenichi Shinkai, Masaharu J Infect Chemother Case Report A 49-year-old Japanese male was managed by mechanical ventilation due to coronavirus disease 2019 (COVID-19) pneumonia. Favipiravir as an antiviral therapy, and anti-inflammatory treatment were administered. SARS-CoV-2 RNA was detected in serum by the loop-mediated isothermal amplification (LAMP) method on Day 9; favipiravir treatment was continued. On Day 13, negative serum RNA was confirmed, followed by mechanical ventilation was removed. On Day 23, LAMP negative was confirmed in nasopharynx, after that the patient discharged on Day 27. We could treat successfully for severe COVID-19 pneumonia based on the LAMP method. We consider this method will be useful in COVID-19 treatment. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021-02 2020-10-10 /pmc/articles/PMC7547611/ /pubmed/33268271 http://dx.doi.org/10.1016/j.jiac.2020.10.011 Text en © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Hirouchi, Takatomo Ota, Shinichiro Mashima, Dai Boku, Ryuichi Yoshida, Yuto Iwata, Koki Shinada, Kanako Matsumoto, Takashi Morikawa, Miwa Sato, Takashi Shinoda, Masahiro Kamachi, Kenichi Shinkai, Masaharu A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful |
title | A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful |
title_full | A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful |
title_fullStr | A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful |
title_full_unstemmed | A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful |
title_short | A case of COVID-19 pneumonia successfully treated with favipiravir (Avigan) in which serum SARS-CoV-2 RNA detected by LAMP method was clinically useful |
title_sort | case of covid-19 pneumonia successfully treated with favipiravir (avigan) in which serum sars-cov-2 rna detected by lamp method was clinically useful |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547611/ https://www.ncbi.nlm.nih.gov/pubmed/33268271 http://dx.doi.org/10.1016/j.jiac.2020.10.011 |
work_keys_str_mv | AT hirouchitakatomo acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT otashinichiro acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT mashimadai acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT bokuryuichi acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT yoshidayuto acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT iwatakoki acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT shinadakanako acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT matsumototakashi acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT morikawamiwa acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT satotakashi acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT shinodamasahiro acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT kamachikenichi acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT shinkaimasaharu acaseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT hirouchitakatomo caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT otashinichiro caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT mashimadai caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT bokuryuichi caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT yoshidayuto caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT iwatakoki caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT shinadakanako caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT matsumototakashi caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT morikawamiwa caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT satotakashi caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT shinodamasahiro caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT kamachikenichi caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful AT shinkaimasaharu caseofcovid19pneumoniasuccessfullytreatedwithfavipiraviraviganinwhichserumsarscov2rnadetectedbylampmethodwasclinicallyuseful |